CN1151270C - 诊断结核杆菌及其耐药性的dna芯片 - Google Patents
诊断结核杆菌及其耐药性的dna芯片 Download PDFInfo
- Publication number
- CN1151270C CN1151270C CNB001337963A CN00133796A CN1151270C CN 1151270 C CN1151270 C CN 1151270C CN B001337963 A CNB001337963 A CN B001337963A CN 00133796 A CN00133796 A CN 00133796A CN 1151270 C CN1151270 C CN 1151270C
- Authority
- CN
- China
- Prior art keywords
- ctg
- agc
- caa
- cag
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000018 DNA microarray Methods 0.000 title claims abstract description 18
- 241000193830 Bacillus <bacterium> Species 0.000 title claims description 30
- 206010052804 Drug tolerance Diseases 0.000 title 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims abstract description 6
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims abstract description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 5
- 239000010703 silicon Substances 0.000 claims abstract description 5
- 239000000523 sample Substances 0.000 claims description 50
- 239000000126 substance Substances 0.000 claims description 7
- 241000023308 Acca Species 0.000 claims description 3
- 239000012876 carrier material Substances 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 abstract description 18
- 238000003745 diagnosis Methods 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 5
- 239000003298 DNA probe Substances 0.000 abstract description 3
- 239000011521 glass Substances 0.000 abstract description 2
- 244000052616 bacterial pathogen Species 0.000 abstract 4
- 206010059866 Drug resistance Diseases 0.000 abstract 3
- 206010064571 Gene mutation Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 38
- 238000012217 deletion Methods 0.000 description 10
- 230000037430 deletion Effects 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 4
- 229960001225 rifampicin Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000001215 fluorescent labelling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 101000963440 Bacillus subtilis (strain 168) Biotin carboxylase 1 Proteins 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- DBNLXHGDGBUCDV-KKUMJFAQSA-N Gln-Phe-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O DBNLXHGDGBUCDV-KKUMJFAQSA-N 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 101150090202 rpoB gene Proteins 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 239000000814 tuberculostatic agent Substances 0.000 description 2
- GSMPSRPMQQDRIB-WHFBIAKZSA-N Asp-Gln Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O GSMPSRPMQQDRIB-WHFBIAKZSA-N 0.000 description 1
- 101000782621 Bacillus subtilis (strain 168) Biotin carboxylase 2 Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100282369 Caenorhabditis elegans gcc-2 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DXJZITDUDUPINW-WHFBIAKZSA-N Gln-Asn Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O DXJZITDUDUPINW-WHFBIAKZSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- PYOHODCEOHCZBM-RYUDHWBXSA-N Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 PYOHODCEOHCZBM-RYUDHWBXSA-N 0.000 description 1
- 101150064359 SLC6A1 gene Proteins 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 101150041549 tgt-2 gene Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
表1 | ||||||
受影响胺酸 | 胺酸改变 | DNA改变 | 出现数目 | 突变数目 | 突变探针 | 非突变探针 |
505 | Phe->Leu | TTC->TTG | 2 | 0.38% | M1 | W1 |
509 | Ser->Thr | AGC->ACC | 1 | 0.19% | W2 | |
511 | Leu->Pro | CTG->CCG | 16 | 3.08% | M2 | W2,W3,W4 |
511 | Leu->Arg | CTG->CGG | 3 | 0.58% | M3 | W2,W3,W4 |
512 | Ser->Thr | AGC->ACC | 2 | 0.38% | M4 | W2,W3,W4 |
513 | Gln->Glu | CAA->GAA | 3 | 0.58% | M5 | W2,W3,W4,W5 |
513 | Gln->Lys | CAA->AAA | 1 | 0.19% | M6 | W2,W3,W4,W5 |
513 | Gln->Pro | CAA->CCA | 7 | 1.35% | M7 | W2,W3,W4,W5 |
513 | Gln->Leu | CAA->CTA | 15 | 2.88% | M8 | W2,W3,W4,W5 |
513 514 515 | Gln Phe Met deletion,Leu insertion | AAT TCA deletion | 1 | 0.19% | M11 | W2,W3,W4,W5,W6 |
514 514 515 516 | Gln Phe Met Asp deletion,His insertion | AAT TCA TGG deletion | 2 | 0.38% | M12 | W2,W3,W4,W5,W6 |
514 | Phe insertion | TTC insertion | 7 | 1.35% | M9 | W3,W4,W5,W6 |
514 515 | Phe Met insertion | TTC ATG insertion | 1 | 0.19% | M10 | W5,W6 |
515 | Met->Val | ATG->GTG | 3 | 0.58% | M15 | W4,W5,W6 |
516 | Asp->Tyr | GAC->TAC | 8 | 1.54% | M16 | W5,W6 |
516 | Asp->Val | GAC->GTC | 30 | 5.77% | M17 | W5,W6 |
516 | Asp->Ala | GAC->GCC | 2 | 0.38% | M18 | W5,W6 |
516 | Asp->Gly | GAC->GGC | 1 | 0.19% | M19 | W5,W6 |
516 | Asp->Glu | GAC->GAA | 1 | 0.19% | M20 | W5,W6 |
516 | Asp->Glu | GAC->GAG | 2 | 0.38% | M21 | W5,W6 |
516 | Asp->Gly | GAC->GGG | 1 | 0.19% | W5,W6 | |
516 517 | Asp Gln deletion | GAC CAG deletion | 10 | 1.92% | M13 | W5,W6 |
517 518 | Gln Asn deletion | CAG AAC deletion | 1 | 0.19% | W5,W6 | |
518 | Asn deletion | AAC deletion | 4 | 0.77% | M14 | W6 |
521 | Leu->Met | CTG->ATG | 1 | 0.19% | W7 | |
522 | Ser->Gln | TCG->TTG | 5 | 0.96% | M22 | W7 |
522 | Ser->Leu | TCG->CAG | 7 | 1.35% | M23 | W7 |
523 | Gly->Trp | GGG->TGG | 1 | 0.19% | W7,W8 | |
525 | Thr->Asn | ACC->AAC | 1 | 0.19% | M24 | W8,W9 |
525 | Asp->Tyr | ACC->ATC | 1 | 0.19% | W8,W9 | |
526 | His->Asn | CAC->AAC | 3 | 0.58% | M25 | W8,W9 |
526 | His->Thr | CAC->ACC | 1 | 0.19% | M26 | W8,W9 |
526 | His->Pro | CAC->CCC | 7 | 1.35% | M27 | W8,W9 |
526 | His->Arg | CAC->CGC | 22 | 4.23% | M28 | W8,W9 |
526 | His->Leu | CAC->CTC | 11 | 2.12% | M29 | W8,W9 |
526 | His->Cys | CAC->TGC | 3 | 0.58% | M30 | W8,W9 |
526 | His->Tyr | CAC->TAC | 86 | 16.54% | M31 | W8,W9 |
526 | His->Asp | CAC->GAC | 37 | 7.12% | M32 | W8,W9 |
526 | His->Gln | CAC->CAG | 1 | 0.19% | M33 | W8,W9 |
526 | His->Gln | CAC->CAA | 1 | 0.19% | W8,W9 | |
527 | Lys->Gln | AAG->CAG | 1 | 0.19% | W8,W9,W10 | |
529 | Arg->Gln | CGA->CAA | 1 | 0.19% | M34 | W10,W11 |
531 | Ser->Leu | TCG->TTG | 173 | 33.27% | M35 | W10,W11,W12 |
531 | Ser->Trp | TCG->TGG | 14 | 2.69% | M36 | W10,W11,W12 |
531 | Ser->Cys | TCG->TGT | 2 | 0.38% | M37 | W10,W11,W12 |
533 | Leu->Pro | CTG->CCG | 15 | 2.88% | M38 | W11,W12 |
541 | Glu->Gly | GAC->GAT | 1 | 0.19% | ||
553 | Ser->Ala | TCG->GCG | 1 | 0.19% | ||
520 | 100.00% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001337963A CN1151270C (zh) | 2000-10-31 | 2000-10-31 | 诊断结核杆菌及其耐药性的dna芯片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001337963A CN1151270C (zh) | 2000-10-31 | 2000-10-31 | 诊断结核杆菌及其耐药性的dna芯片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1351176A CN1351176A (zh) | 2002-05-29 |
CN1151270C true CN1151270C (zh) | 2004-05-26 |
Family
ID=4595925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001337963A Expired - Fee Related CN1151270C (zh) | 2000-10-31 | 2000-10-31 | 诊断结核杆菌及其耐药性的dna芯片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1151270C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8044184B2 (en) * | 2004-04-26 | 2011-10-25 | Wako Pure Chemical Industries, Ltd. | Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith |
RU2717655C2 (ru) | 2014-10-10 | 2020-03-24 | Рутгерс, Зе Стейт Юниверсити Оф Нью-Джерси | Праймеры и зонды для полимеразной цепной реакции для обнаружения mycobacterium tuberculosis |
CN114540524A (zh) * | 2022-04-01 | 2022-05-27 | 领航基因科技(杭州)有限公司 | 一种用于结核分枝杆菌及其耐药性的数字pcr检测试剂盒 |
-
2000
- 2000-10-31 CN CNB001337963A patent/CN1151270C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1351176A (zh) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7906286B2 (en) | Probe set, probe carrier, and method for determining and identifying fungus | |
EP1921167A1 (en) | Probe, probe set, probe-immobilized carrier, and genetic testing method | |
EP1921162A1 (en) | Probe, probe set, probe-immobilized carrier, and genetic testing method | |
EP1921164A1 (en) | Probe, probe set, probe-immobilized carrier, and genetic testing method | |
EP1208222A2 (en) | Customized oligonucleotide microchips that convert multiple genetic information to simple patterns | |
EP0652971A4 (en) | GENE DETECTION SYSTEM. | |
CN101054601A (zh) | 一种检测细胞色素p450酶系突变位点的寡核苷酸探针及基因芯片 | |
CN1256714A (zh) | 使用三核苷酸重复序列诊断神经精神疾病的方法及试剂盒 | |
CN1739027A (zh) | 预测动物行为 | |
CN1444662A (zh) | 用于分支杆菌菌种鉴定和抗药性检测的诊断试剂盒及其制备方法 | |
CN1151270C (zh) | 诊断结核杆菌及其耐药性的dna芯片 | |
CN1153969C (zh) | 结核分支杆菌耐药性检测芯片及其制作方法和应用方法 | |
EP1480155A2 (en) | Information processing apparatus, information processing method, storage medium and program | |
CN1536090A (zh) | 食源性致病菌快速检测基因芯片及其应用 | |
CN1982473A (zh) | 检测hiv对逆转录酶抑制剂抗性的基因芯片及试剂盒 | |
CN1334872A (zh) | 将寡核苷酸固定在载体上的方法 | |
CN101230404A (zh) | 同时检测多种混合感染病毒的方法 | |
US8178343B2 (en) | Gene cluster diagnosis apparatus | |
CN1151271C (zh) | 检测及鉴别肠病毒的方法及其所用之引物及探针 | |
CN101051026A (zh) | 耐万古霉素肠球菌双重实时荧光pcr检测方法 | |
CN1283994C (zh) | 一种生物芯片的二维编码标记方法 | |
CN1587418A (zh) | 曲霉菌基因检测芯片及其制作方法和使用方法 | |
CN1450173A (zh) | 与sars相关的冠状病毒全基因组芯片及其用途 | |
CN2560946Y (zh) | 纳米金标记银染肝炎检测型基因芯片 | |
CN1974593A (zh) | 一种基因组特异性扩增引物及其标记小麦α-醇溶蛋白的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: YANENG BIOTECHNOLOGY (SHENZHEN) CO., LTD. Free format text: FORMER OWNER: YANG MENG Effective date: 20020513 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20020513 Address after: 518000, EF building, 10 floor, Mao Mao Building, 59 news Road, Guangdong, Shenzhen Applicant after: Yaneng Biotechnology (Shenzhen) Co., Ltd. Address before: Department of biology and chemistry, City University Hong Kong, 83 Tat Tat Road, Hongkong Applicant before: Yang Mengsu |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GANGLONG BIOLOGY TECHNOLOGY ( SHENZHEN ) CO., LTD Free format text: FORMER OWNER: YANENG BIOTECHNOLOGY (SHENZHEN) CO., LTD. Effective date: 20070727 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070727 Address after: 518057 high tech Zone of Shenzhen city in a biological incubator building 2310 Patentee after: Genetal Pharmaceuticals (Shenzhen) Co.,Ltd. Address before: 518000, EF building, 10 floor, Mao Mao Building, 59 news Road, Guangdong, Shenzhen Patentee before: Decipher Bioscience (Shenzhen) Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040526 Termination date: 20191031 |
|
CF01 | Termination of patent right due to non-payment of annual fee |